A quantitative PCR assay for the detection of low amounts of malignant cells in multiple myeloma

Annals of Oncology

Volumn 8, Issue 7, 1997, Pages 633-636

  Cremer, F W ^a   Kiel, K ^a   Wallmeier, M ^a   Goldschmidt, H ^a   Moos, M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Limiting dilutions; Minimal residual disease; Multipie myeloma; Quantitative PCR

Indexed keywords

ARTICLE; BONE MARROW EXAMINATION; CALCULATION; DATA ANALYSIS; DNA DETERMINATION; DNA REPLICATION; GENE AMPLIFICATION; MULTIPLE MYELOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS;

BASE SEQUENCE; DNA PRIMERS; HUMANS; MOLECULAR SEQUENCE DATA; MULTIPLE MYELOMA; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION;

EID: 0030842780     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008286803199     Document Type: Article

References (15)

1. Attal M, Harousseau JL, Stoppa AM et al. A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 1996; 335: 91-7.
2. Schiller GJ, Vescio RA, Freytes C et al. Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995; 86: 390-7.
3. Vescio RA, Han EJ, Schiller GJ et al. Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts. Bone Marrow Transplant 1996; 18: 103-10.
4. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. J Immunol 1981; 126: 1614-9.
5. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt Biochem 1987; 162: 156-9.
6. Brisco MJ, Tan LW, Orsborn AM et al. Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population. Br J Haematol 1990; 75: 163-7.
7. Moos M, Schulz R, Cremer F et al. Detection of minimal residual disease by polymerase chain reaction (PCR) in B-cell malignancies. Stem cells 1995; 13 (Suppl 3): 42-51.
8. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237-8.
9. Hohaus S, Goldschmidt H, Ehrhardt R et al. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp Hematol 1993; 21: 508-14.
10. Wiesner RJ. Direct quantitation of picomolar concentrations of mRNAs by mathematical analysis of a reverse transcription/ exponential polymerase chain reaction assay. Nucleic Acids Res 1992; 51: 5863-4.
11. Brisco MJ, Condon J, Sykes PJ et al. Detection and quantitation of neoplastic cells in acute lymphoblastic leukaemia, by use of the polymerase chain reaction. Br J Haematol 1991; 79: 211-7.
12. Sykes PJ, Neoh SH, Brisco MJ et al. Quantitation of targets for PCR by use of limiting dilutions. Biotechniques 1992; 13: 444-9.
13. Corradini P, Voena C, Astolfi M et al. High-dose sequential chemoradiotherapy in multiple myeloma: Residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting. Blood 1995; 85: 1596-602.
14. Billadeau D, Quam L, Thomas W et al. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood 1992; 80: 1818-24.
15. Björkstrand B, Ljungman P, Bird JM et al. Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma. Bone Marrow Transplant 1995; 15: 367-71.